Catalyst Wire Dossier Catalyst Wire Dossier

CANASA

Mesalamine · Allergan, Inc.
Drug timelines are a Plus or Pro feature.

14 regulatory and trial events tracked for CANASA, covering 2006-06-08 to 2023-10-24. Get the full timeline:

Most recent: FDA Approved: CANASA — Supplemental Application (Allergan, Inc.)

See pricing